MARKET

ATHX

ATHX

Athersys Inc
NASDAQ
1.820
+0.120
+7.06%
After Hours: 1.790 -0.03 -1.65% 17:05 02/06 EST
OPEN
1.720
PREV CLOSE
1.700
HIGH
1.840
LOW
1.680
VOLUME
584.88K
TURNOVER
0
52 WEEK HIGH
33.25
52 WEEK LOW
0.5031
MARKET CAP
23.54M
P/E (TTM)
-0.2276
1D
5D
1M
3M
1Y
5Y
Alibaba Group, Bilibili, Lufax Holding among premarket losers' pack
Seeking Alpha · 01/30 13:31
BRIEF-Athersys Inc Has Until April 12 To Regain Nasdaq Compliance Under Market Value Standard
Reuters · 01/25 23:20
ATHX, AVCT and TPST among mi-day movers
Seeking Alpha · 01/11 17:44
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 01/11 17:30
BRIEF-Athersys Provides Multistem Clinical Update
Reuters · 01/09 13:58
Athersys Provides MultiStem Clinical Update
Benzinga · 01/09 13:41
BRIEF-Athersys Appoints Joseph Nolan To Its Board Of Directors
Reuters · 01/05 21:44
BRIEF-Athersys Receives Nasdaq Notification About Not Satisfying Continued Listing Requirement
Reuters · 12/29/2022 21:52
More
About ATHX
Athersys, Inc. is a biotechnology company. It is engaged in the discovery and development of therapeutic product candidates. Its MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product and is in late-stage clinical development. The MultiStem cell therapy includes treatment of critical care indications, neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease, and other conditions. MultiStem cell therapy is manufactured from human stem cells obtained from adult bone marrow and these cells may alternatively be obtained from other tissue sources. It is conducting a Phase III clinical trial of MultiStem cell therapy for the treatment of ischemic stroke, referred to as MASTERS-2. It is enrolling a pivotal Phase II/III clinical trial evaluating MultiStem cell therapy in COVID-19 induced and other pathogen-induced acute respiratory distress syndrome (ARDS) patients.

Webull offers kinds of Athersys Inc stock information, including NASDAQ:ATHX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATHX stock methods without spending real money on the virtual paper trading platform.